
Reset all filters
01 9Gowling WLG
Reset all filters
01 32740806
02 32905798
03 32925310
Reset all filters
01 9ATEZOLIZUMAB
Reset all filters
01 9SOLUTION
Reset all filters
01 32029-12-08
02 32034-03-12
03 32034-09-26
Patent Expiration Date : 2029-12-08
Date Granted : 2021-07-20
Brand Name : TECENTRIQ
Patent Number : 2740806
Filing Date : 2009-12-08
Strength per Unit : 1200mg / 20ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2029-12-08
Date Granted : 2021-07-20
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-09-26
Date Granted : 2022-12-06
Brand Name : TECENTRIQ
Patent Number : 2925310
Filing Date : 2014-09-26
Strength per Unit : 1200mg / 20ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2034-09-26
Date Granted : 2022-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-03-12
Date Granted : 2023-01-24
Brand Name : TECENTRIQ
Patent Number : 2905798
Filing Date : 2014-03-12
Strength per Unit : 1200mg / 20ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2034-03-12
Date Granted : 2023-01-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-08
Date Granted : 2021-07-20
Brand Name : TECENTRIQ
Patent Number : 2740806
Filing Date : 2009-12-08
Strength per Unit : 840mg / 14ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2029-12-08
Date Granted : 2021-07-20
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-09-26
Date Granted : 2022-12-06
Brand Name : TECENTRIQ
Patent Number : 2925310
Filing Date : 2014-09-26
Strength per Unit : 840mg / 14ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2034-09-26
Date Granted : 2022-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-03-12
Date Granted : 2023-01-24
Brand Name : TECENTRIQ
Patent Number : 2905798
Filing Date : 2014-03-12
Strength per Unit : 840mg / 14ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : INTRAVENOUS
Patent Expiration Date : 2034-03-12
Date Granted : 2023-01-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-03-12
Date Granted : 2023-01-24
Brand Name : TECENTRIQ SC
Patent Number : 2905798
Filing Date : 2014-03-12
Strength per Unit : 125 mg / ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2034-03-12
Date Granted : 2023-01-24
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2034-09-26
Date Granted : 2022-12-06
Brand Name : TECENTRIQ SC
Patent Number : 2925310
Filing Date : 2014-09-26
Strength per Unit : 125 mg / ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2034-09-26
Date Granted : 2022-12-06
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2029-12-08
Date Granted : 2021-07-20
Brand Name : TECENTRIQ SC
Patent Number : 2740806
Filing Date : 2009-12-08
Strength per Unit : 125 mg / ml
Dosage Form : SOLUTION
Human Or VET : Human
Route of Administration : SUBCUTANEOUS
Patent Expiration Date : 2029-12-08
Date Granted : 2021-07-20
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF